British Journal of Cancer - Table of Contents alert Volume 116 Issue 3

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 116, Issue 3 (277-414) Published online 31 January 2017 In this issue Review Clinical Studies Translational Therapeutics Molecular Diagnostics Genetics & Genomics Epidemiology Letters to the Editor Also new today Advance online publication Digital Edition Sign up for e-alerts Recommend to your library Web feed Subscribe Review Top Tumour microenvironment factors shaping the cancer metabolism landscape Dimitrios Anastasiou Br J Cancer 2017 116: 277-286; advance online publication, December 22, 2016; 10.1038/bjc.2016.412 Abstract | Full Text Clinical Studies Top Better resource utilisation and quality of care for ovarian cancer patients using internet-based pathology review S Kommoss, F Kommoss, J Diebold, S Lax, D Schmidt, A Staebler, A du Bois and J Pfisterer Br J Cancer 2017 116: 287-292; advance online publication, December 22, 2016; 10.1038/bjc.2016.416 Abstract | Full Text Immediate chest X-ray for patients at risk of lung cancer presenting in primary care: randomised controlled feasibility trial Richard D Neal, Allan Barham, Emily Bongard, Rhiannon Tudor Edwards, Jim Fitzgibbon, Gareth Griffiths, Willie Hamilton, Kerenza Hood, Annmarie Nelson, David Parker, Cath Porter, Hayley Prout, Kirsty Roberts, Trevor Rogers, Emma Thomas-Jones, Angela Tod, Seow Tien Yeo and Chris N Hurt Br J Cancer 2017 116: 293-302; advance online publication, January 10, 2017; 10.1038/bjc.2016.414 Abstract | Full Text Phase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma: a stratified type I–type II study from the GINECO group P-E Heudel, M Fabbro, C Roemer-Becuwe, M C Kaminsky, A Arnaud, F Joly, S Roche-Forestier, J Meunier, C Foa, B You, F Priou, Y Tazi, A Floquet, F Selle, D Berton-Rigaud, A Lesoin, E Kalbacher, A Lortholary, L Favier, I Treilleux and I Ray-Coquard Br J Cancer 2017 116: 303-309; advance online publication, January 10, 2017; 10.1038/bjc.2016.430 Abstract | Full Text The impact of body composition parameters on ipilimumab toxicity and survival in patients with metastatic melanoma Louise E Daly, Derek G Power, Áine O'Reilly, Paul Donnellan, Samantha J Cushen, Kathleen O'Sullivan, Maria Twomey, David P Woodlock, Henry P Redmond and Aoife M Ryan Br J Cancer 2017 116: 310-317; advance online publication, January 10, 2017; 10.1038/bjc.2016.431 Abstract | Full Text Translational Therapeutics Top Serum LDH predicts benefit from bevacizumab beyond progression in metastatic colorectal cancer Federica Marmorino, Lisa Salvatore, Cecilia Barbara, Giacomo Allegrini, Lorenzo Antonuzzo, Gianluca Masi, Fotios Loupakis, Beatrice Borelli, Silvana Chiara, Maria Chiara Banzi, Emanuela Miraglio, Domenico Amoroso, Francesco Dargenio, Andrea Bonetti, Angelo Martignetti, Myriam Paris, Daniela Tomcikova, Luca Boni, Alfredo Falcone and Chiara Cremolini Br J Cancer 2017 116: 318-323; advance online publication, January 12, 2017; 10.1038/bjc.2016.413 Abstract | Full Text Impact of CTLA-4 blockade in conjunction with metronomic chemotherapy on preclinical breast cancer growth Karla Parra, Paloma Valenzuela, Natzidielly Lerma, Alejandra Gallegos, Luis C Reza, Georgialina Rodriguez, Urban Emmenegger, Teresa Di Desidero, Guido Bocci, Mitchell S Felder, Marian Manciu, Robert A Kirken and Giulio Francia Br J Cancer 2017 116: 324-334; advance online publication, January 5, 2017; 10.1038/bjc.2016.429 Abstract | Full Text Antitumour activity of trabectedin in myelodysplastic/myeloproliferative neoplasms Michela Romano, Matteo Giovanni Della Porta, Anna Gallì, Nicolò Panini, Simonetta Andrea Licandro, Ezia Bello, Ilaria Craparotta, Vittorio Rosti, Elisa Bonetti, Richard Tancredi, Marianna Rossi, Laura Mannarino, Sergio Marchini, Luca Porcu, Carlos M Galmarini, Alberto Zambelli, Marco Zecca, Franco Locatelli, Mario Cazzola, Andrea Biondi, Alessandro Rambaldi, Paola Allavena, Eugenio Erba and Maurizio D'Incalci Br J Cancer 2017 116: 335-343; advance online publication, January 10, 2017; 10.1038/bjc.2016.424 Abstract | Full Text Mathematical optimisation of the cisplatin plus etoposide combination for managing extensive-stage small-cell lung cancer patients C Faivre, R El Cheikh, D Barbolosi and F Barlesi Br J Cancer 2017 116: 344-348; advance online publication, January 12, 2017; 10.1038/bjc.2016.439 Abstract | Full Text Molecular Diagnostics Top Diagnosis of pancreaticobiliary malignancy by detection of minichromosome maintenance protein 5 in biliary brush cytology Margaret G Keane, Matthew T Huggett, Michael H Chapman, Gavin J Johnson, George J Webster, Douglas Thorburn, James Mackay and Stephen P Pereira Br J Cancer 2017 116: 349-355; advance online publication, January 12, 2017; 10.1038/bjc.2016.447 Abstract | Full Text Soluble VE-cadherin in metastatic breast cancer: an independent prognostic factor for both progression-free survival and overall survival Pauline Rochefort, Sylvie Chabaud, Jean-Yves Pierga, Olivier Tredan, Etienne Brain, François-Clément Bidard, Camille Schiffler, Helena Polena, Abir Khalil-Mgharbel, Isabelle Vilgrain and Thomas Bachelot Br J Cancer 2017 116: 356-361; advance online publication, January 5, 2017; 10.1038/bjc.2016.427 Abstract | Full Text Epithelial to mesenchymal transition and HPV infection in squamous cell oropharyngeal carcinomas: the papillophar study Marine Lefevre, Alexandra Rousseau, Thomas Rayon, Véronique Dalstein, Christine Clavel, Agnès Beby-Defaux, Jean-Luc Pretet, Patrick Soussan, Myriam Polette, Jean Lacau Saint Guily, Philippe Birembaut and the Papillophar Study Group Br J Cancer 2017 116: 362-369; advance online publication, January 10, 2017; 10.1038/bjc.2016.434 Abstract | Full Text Regulation of anoikis resistance by NADPH oxidase 4 and epidermal growth factor receptor Hyeryeong Kim, Jee Young Sung, Eun-Kyung Park, Seongho Kho, Kyung Hee Koo, Seog-Yun Park, Sung-Ho Goh, Yoon Kyung Jeon, Sekyung Oh, Byung-Kiu Park, Yong-Keun Jung and Yong-Nyun Kim Br J Cancer 2017 116: 370-381; advance online publication, January 12, 2017; 10.1038/bjc.2016.440 Abstract | Full Text Genetics & Genomics Top CYP3A7*1C allele is associated with reduced levels of 2-hydroxylation pathway oestrogen metabolites Deepti Sood, Nichola Johnson, Pooja Jain, Alexandros P Siskos, Mark Bennett, Clare Gilham, Marta Cecilia Busana, Julian Peto, Isabel dos-Santos-Silva, Hector C Keun and Olivia Fletcher Br J Cancer 2017 116: 382-388; advance online publication, January 10, 2017; 10.1038/bjc.2016.432 Abstract | Full Text Epidemiology Top The impact of age on complications, survival, and cause of death following colon cancer surgery Christopher T Aquina, Supriya G Mohile, Mohamedtaki A Tejani, Adan Z Becerra, Zhaomin Xu, Bradley J Hensley, Reza Arsalani-Zadeh, Francis P Boscoe, Maria J Schymura, Katia Noyes, John RT Monson and Fergal J Fleming Br J Cancer 2017 116: 389-397; advance online publication, January 5, 2017; 10.1038/bjc.2016.421 Abstract | Full Text Ninth grade school performance in Danish childhood cancer survivors Klaus Kaae Andersen, Anne Katrine Duun-Henriksen, Marie Hoffmann Frederiksen and Jeanette Falck Winther Br J Cancer 2017 116: 398-404; advance online publication, January 12, 2017; 10.1038/bjc.2016.438 Abstract | Full Text Effect of low-dose aspirin use on survival of patients with gastrointestinal malignancies; an observational study M A Frouws, E Bastiaannet, R E Langley, W K Chia, M P P van Herk-Sukel, V E P P Lemmens, H Putter, H H Hartgrink, B A Bonsing, C J H Van de Velde, J E A Portielje and G J Liefers Br J Cancer 2017 116: 405-413; advance online publication, January 10, 2017; 10.1038/bjc.2016.425 Abstract | Full Text Letters to the Editor Top Comment on ‘Statin use and all-cancer survival: prospective results from the Women’s Health Initiative’ Luca Mascitelli and Mark R Goldstein Br J Cancer 2017 116: e1; advance online publication, December 6, 2016; 10.1038/bjc.2016.395 Full Text Reply to Comment on ‘Statin use and all-cancer survival: prospective results from the Women’s Health Initiative’ Ange Wang, Aaron K Aragaki, Jean Y Tang, Allison W Kurian, JoAnn E Manson, Rowan T Chlebowski, Michael Simon, Pinkal Desai, Sylvia Wassertheil-Smoller, Simin Liu, Stephen Kritchevsky, Heather A Wakelee and Marcia L Stefanick Br J Cancer 2017 116: e2; advance online publication, December 6, 2016; 10.1038/bjc.2016.396 Full Text Comment on ‘Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome’ Paolo Dell'Oglio, Armando Stabile, Giorgio Gandaglia and Alberto Briganti Br J Cancer 2017 116: e3; advance online publication, October 25, 2016; 10.1038/bjc.2016.346 Full Text Reply to ‘Comment on “Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome”’ Daniel M Berney on behalf of the Transatlantic Prostate Group Br J Cancer 2017 116: e4; advance online publication, October 25, 2016; 10.1038/bjc.2016.347 Full Text Comment on ‘Molecular evidence of viral DNA in non-small cell lung cancer and non-neoplastic lung’ Antonio Ponzetto, Natale Figura and John Holton Br J Cancer 2017 116: e5; advance online publication, October 20, 2016; 10.1038/bjc.2016.338 Full Text Reply to: Comment on ‘Molecular evidence of viral DNA in non-small cell lung cancer and non-neoplastic lung’ Lary A Robinson, Crystal J Jaing, Christine Pierce Campbell, Anthony Magliocco, Yin Xiong, Genevra Magliocco, James B Thissen and Scott Antonia Br J Cancer 2017 116: e6; advance online publication, October 20, 2016; 10.1038/bjc.2016.339 Full Text Comment on ‘MicroRNA-214 suppresses growth, migration and invasion through a novel target, high mobility group AT-hook 1, in human cervical and colorectal cancer cells’ Ion Cristóbal, Blanca Torrejón, Juan Madoz-Gúrpide, Federico Rojo and Jesús García-Foncillas Br J Cancer 2017 116: e7; advance online publication, December 20, 2016; 10.1038/bjc.2016.409 Full Text Reply: Comment on ‘MicroRNA-214 suppresses growth, migration and invasion through a novel target, high mobility group AT-hook 1, in human cervical and colorectal cancer cells’ Karthik Subramanian Chandrasekaran, Anusha Sathyanarayanan and Devarajan Karunagaran Br J Cancer 2017 116: e8; advance online publication, December 20, 2016; 10.1038/bjc.2016.410 Full Text Advertisement Breast Cancer Now Catalyst Programme Grants  Apply Now We are inviting Expressions of Interest from researchers who are interested in using Pfizer drugs for preclinical or clinical breast cancer research from teams based at a single site or multiple sites in the UK and Europe. To apply please visit our website. Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2017 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.